Zealand Pharma A/S (NASDAQ:ZEAL)

24.84
Delayed Data
As of Sep 20
 0.00 / 0.00%
Today’s Change
11.51
Today|||52-Week Range
24.96
+113.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$821.7M

Company Description

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.

Contact Information

Zealand Pharma A/S
Smedeland 36
Glostrup Zealand 2600
P:(458) 877-3600
Investor Relations:
(455) 060-3778

Employees

Shareholders

Other institutional8.28%
Mutual fund holders0.95%
Individual stakeholders--

Top Executives

Emmanuel DulacPresident & Chief Executive Officer
Ivan M. MøllerCFO & SVP-Technical Development & Operations
Adam SteensbergChief Medical & Development Officer, Executive VP
Rie Schultz HansenVice President-Research
Christian ThorkildsenProject Director